Titel och upphov Medication development for the treatment of cocaine dependence : issues in clinical efficacy trials
Utgivning, distribution etc. National Institute on Drug Abuse, Rockville, Md : 1997
Fysisk beskrivning
Serietitel - biuppslagsform NIDA research monograph series ; 175 NIH publication ; 98-4125
Anmärkning: Allmän
Anmärkning: Innehållsbeskrivning, sammanfattning Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research. Overview of potential treatment medications for cocaine dependence. Methodologic recommendations for cocaine abuse clinical trials: a clinican-researcher's perspective. Management of clinical trials with new medications for cocaine dependence and abuse. Outcome measurement considerations: pharmacological treatments for substance abuse. Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials. Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence. The addiction severity index in clinical efficacy trials of medications for cocaine dependence. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment. Treatment effectiveness score as an outcome measure in clinical trials. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis. Quantitative urine levels of cocaine and other substances of abuse. Use of quantitative urinalysis in monitoring cocaine use. Is quantitative urinalysis more sensitive? Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine. (From the table of contents)
Term
Indexterm - Okontrollerad
Personnamn
Institutionsnamn National Institute on Drug Abuse
*000 am
*00116448
*007cr
*008070120s1997||||xxu||||e||||||||||0|eng|d
*24510$aMedication development for the treatment of cocaine dependence :$bissues in clinical efficacy trials
*260 $aRockville, Md :$bNational Institute on Drug Abuse,$c1997
*300 $a329 s :$bill.
*440 $aNIDA research monograph series ;$v175
*440 $aNIH publication ;$v98-4125
*500 $aE-bok
*520 $aGoals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research. Overview of potential treatment medications for cocaine dependence. Methodologic recommendations for cocaine abuse clinical trials: a clinican-researcher's perspective. Management of clinical trials with new medications for cocaine dependence and abuse. Outcome measurement considerations: pharmacological treatments for substance abuse. Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials. Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence. The addiction severity index in clinical efficacy trials of medications for cocaine dependence. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment. Treatment effectiveness score as an outcome measure in clinical trials. Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis. Quantitative urine levels of cocaine and other substances of abuse. Use of quantitative urinalysis in monitoring cocaine use. Is quantitative urinalysis more sensitive? Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine. (From the table of contents)
*650 4$aCocaine-related disorders
*650 4$aTreatment outcome
*650 4$aPharmacology
*650 4$aDrug therapy
*650 4$aClinical Trials
*650 4$aUrinalysis
*650 4$aPharmacokinetics
*653 $aKokain
*653 $aBehandling
*653 $aFarmakoterapi
*653 $aFarmakokinetik
*653 $aUrinanalys
*7001 $aTai, Betty$eed. et al
*7101 $aNational Institute on Drug Abuse$0124050
*85640$uhttps://archives.drugabuse.gov/sites/default/files/monograph175_0.pdf
^
Det finns inga omdömen till denna titeln.
Klicka här
för att vara den första som skriver ett omdöme.